Biophysical mechanisms of myocardium sodium channelopathies
- 1 March 2024
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 476 (5) , 735-753
Abstract
Genetic variants of gene SCN5A encoding the alpha-subunit of cardiac voltage-gated sodium channel Nav1.5 are associated with various diseases, including long QT syndrome (LQT3), Brugada syndrome (BrS1), and progressive cardiac conduction disease (PCCD). In the last decades, the great progress in understanding molecular and biophysical mechanisms of these diseases has been achieved. The LQT3 syndrome is associated with gain-of-function of sodium channels Nav1.5 due to impaired inactivation, enhanced activation, accelerated recovery from inactivation or the late current appearance. In contrast, BrS1 and PCCD are associated with the Nav1.5 loss-of-function, which in electrophysiological experiments can be manifested as reduced current density, enhanced fast or slow inactivation, impaired activation, or decelerated recovery from inactivation. Genetic variants associated with congenital arrhythmias can also disturb interactions of the Nav1.5 channel with different proteins or drugs and cause unexpected reactions to drug administration. Furthermore, mutations can affect post-translational modifications of the channels and their sensitivity to pH and temperature. Here we briefly review the current knowledge on biophysical mechanisms of LQT3, BrS1 and PCCD. We focus on limitations of studies that use heterologous expression systems and induced pluripotent stem cells (iPSC) derived cardiac myocytes and summarize our understanding of genotype–phenotype relations of SCN5A mutations.Keywords
Funding Information
- Russian Science Foundation (№22-15-00186, №22-15-00186, №22-15-00186, №22-15-00186)
This publication has 183 references indexed in Scilit:
- Two Distinct Congenital Arrhythmias Evoked by a Multidysfunctional Na + ChannelCirculation Research, 2000
- SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cellsFEBS Letters, 2000
- The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndromeEuropean Heart Journal, 1999
- Temperature dependence of early and late currents in human cardiac wild-type and long Q-T ΔKPQ Na+ channelsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1998
- Novel LQT-3 Mutation Affects Na+Channel Activity Through Interactions Between α- and β1-SubunitsCirculation Research, 1998
- A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndromeFEBS Letters, 1998
- Movement of the Na+ Channel Inactivation Gate during InactivationJournal of Biological Chemistry, 1996
- Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndromeJACC, 1996
- Molecular mechanism for an inherited cardiac arrhythmiaNature, 1995
- SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndromeCell, 1995